Most MedTech failures happen before first-in-human, not because of bad technology, but because of the
wrong preclinical strategy. Startups often overspend on data that doesn’t reduce regulatory risk or move
them closer to clinical use. In this session, you’ll learn how to align preclinical, simulation, and regulatory
strategy to move faster with less waste.
Why Startups Get Stuck Before First-in-Human and How to Fix It – Powered by 3PH Alliance/HRCRS
September 18, 2026 | 02:50 PM (EDT) - 03:35 PM (EDT)
